Plerixafor
NDC 25021-416, Plerixafor, injection, solution, from Sagent Pharmaceuticals.
- Product NDC
- 25021-416
- Status
- Listed
- Labeler
- Sagent Pharmaceuticals
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA206644
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/25021-416 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PLERIXAFOR20 mg/mL
Pharmacologic classes
Hematopoietic Stem Cell Mobilizer [EPC]; Increased Hematopoietic Stem Cell Mobilization [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 25021-416-01 | 25021041601 | 1 VIAL in 1 CARTON (25021-416-01) / 1.2 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/711b7bf7-4385-4365-b12a-ede6c3f1ed45Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=25021-416
Use it
Look up 25021-416 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/25021-416 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 25021-416. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.